A hybridoma monoclonal antibody which reacts with cells carrying the HLA-A2 antigen: evidence for heterogeneity in the expression of HLA-A2

Tissue Antigens. 1981 Nov;18(5):341-8. doi: 10.1111/j.1399-0039.1981.tb01402.x.

Abstract

A monoclonal antibody, FMC 5, has been prepared against human lymphocytes and its reactivity examined. FMC 5 behaves, for the most part, as an anti-HLA-A2 typing serum. However, three small groups of discrepant types were identified, and each provides additional insight into the complexity of the MHC antigens. A small number (5/60) of donors typed as HLA-A2 did not react with FMC 5. A further group (6/35) were HLA-A2 and did react with FMC 5, but lysis was always incomplete in this group. Finally, 13/39 non-A2 donors gave various degrees of reactivity with FMC 5. Lysis in this group was usually incomplete and required a high antibody concentration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology*
  • Antibody Specificity
  • Antigen-Antibody Reactions
  • HLA Antigens / genetics*
  • HLA Antigens / immunology
  • Humans
  • Lymphocytes / immunology
  • Mice
  • Mice, Inbred C57BL / immunology
  • Polymorphism, Genetic*

Substances

  • Antibodies, Monoclonal
  • HLA Antigens